DPP-4 inhibitor (linagliptin)

2 trials

Sponsors

Tokyo Jikei University School of Medicine Kashiwa Hospital, Takeda Hospital Medical Examination Center

Conditions

Type 2 diabetes mellitus.Type-2 diabetic patients (Type-2 diabetic patients with microalbuminuria or nephropathy)

Phase 4

Exploratory study of DPP-4 inhibitor on glycemic control and organ protection in type2 diabetic patients

Active, not recruitingJPRN-UMIN000012171

Tokyo Jikei University School of Medicine Kashiwa HospitalType-2 diabetic patients (Type-2 diabetic patients with microalbuminuria or nephropathy)

Start: 2013-10-30Target: 60Updated: 2026-06-29

Unknown Phase

Influence of linagliptin (DPP-4 inhibitor) on heart autonomic nervous system, heart function and visceral fat area

Active, not recruitingJPRN-UMIN000013191

Takeda Hospital Medical Examination CenterType 2 diabetes mellitus.

Start: 2014-02-20Target: 30Updated: 2026-06-29